Effect of Gut Microbiota-Mediated Tryptophan Metabolism on Inflammaging in Frailty and Sarcopenia
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 01.04.2024 · 79 (4)
DOI: 10.1093/gerona/glae044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 15.02.2024. Verfasst von YuShuang Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China. Hauptthemen laut MEDLINE: Sarcopenia, Frailty, Gastrointestinal Microbiome. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 124 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Taishan Young Scholars Program of Shandong Province, 2023 Qingdao Technology Benefiting Demonstration Project.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Frailty syndrome refers to the nonspecific state of increased body vulnerability and decreased antistress and recovery abilities after stress during aging. Sarcopenia is the major component of frailty and is characterized by the gradual loss of muscle mass, strength, and function with age. Inflammaging is the gradual increase in inflammatory status during aging, and it disrupts immune tolerance, causes physiological changes in tissues, organs, and normal cells, and is related to frailty and sarcopenia. The gut microbiota is an extremely complex and diverse microbial community that coevolves with the host. The composition and structure of the gut microbiota and the metabolism of tryptophan (Trp) significantly change in older adults with frailty and sarcopenia. The gut microbiota participates in regulating the Trp metabolic pathways of kynurenine (Kyn), 5-hydroxytryptamine (5-HT), and indole in the gastrointestinal tract. The Trp metabolites derived from the gut microbiota may synergistically promote the occurrence of age-related frailty and sarcopenia by promoting inflammation in the intestines, nervous system, and muscles. The role and mechanisms of the gut microbiota, Trp metabolism, and inflammaging in age-related frailty and sarcopenia may be a worthwhile research direction to help promote healthy aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Affiliated Hospital of Qingdao University, Qingdao, Shandong, People's Republic of China.
- Department of Gastroenterology, Central Hospital Affiliated to ShanDong First Medical University, Jinan, People's Republic of China.
Förderung
- National Natural Science Foundation of China
- Taishan Young Scholars Program of Shandong Province
- 2023 Qingdao Technology Benefiting Demonstration Project
- Qingdao Chinese Medicine Technology Project
Zitieren
APA
Xu, Y., Mao, T., Wang, Y., Qi, X., Zhao, W., Chen, H., Zhang, C., & Li, X. (2024). Effect of Gut Microbiota-Mediated Tryptophan Metabolism on Inflammaging in Frailty and Sarcopenia. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 79(4). https://doi.org/10.1093/gerona/glae044
Vancouver
Xu Y, Mao T, Wang Y, Qi X, Zhao W, Chen H, et al. Effect of Gut Microbiota-Mediated Tryptophan Metabolism on Inflammaging in Frailty and Sarcopenia. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2024;79(4). doi:10.1093/gerona/glae044
BibTeX
@article{Xu2024,
author = {Xu, YuShuang and Mao, Tao and Wang, YouJun and Qi, XingSi and Zhao, WenJun and Chen, Hao and Zhang, CuiPing and Li, XiaoYu},
title = {Effect of Gut Microbiota-Mediated Tryptophan Metabolism on Inflammaging in Frailty and Sarcopenia},
journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
year = {2024},
volume = {79},
number = {4},
doi = {10.1093/gerona/glae044}
}
EUVIMED